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Abstract 
This study sought to extend knowledge about the previously reported preconscious 
attentional bias for facial emotion in patients with dissociative seizures (DS) by exploring 
whether the finding could be replicated, whilst controlling for concurrent anxiety, 
depression and potentially relevant cognitive impairments.  Patients diagnosed with DS (n = 
38) were compared to healthy controls (n = 43) on a pictorial emotional Stroop test, in 
which backwardly-masked emotional faces (angry, happy, neutral) were processed implicitly.  
The DS group displayed a significantly greater attentional bias to facial emotion relative to 
controls; however, the bias was not specific to negative or positive emotions.  The group 
effect could not be explained by performance on standardised cognitive tests or self-
reported depression/anxiety.  The study provides additional evidence of a disproportionate 
and automatic allocation of attention to facial affect in patients with DS, including both 
positive and negative facial expressions.  Such a tendency could act as a predisposing factor 
for developing DS initially, or may contribute to triggering individuals’ seizures on an 
ongoing basis.  Psychological interventions such as CBT or attentional bias modification 
might be suitable approaches to targeting this bias in clinical practice.   
 
 
Key words: attentional bias, dissociative seizures, emotion, psychogenic non-epileptic 
seizures, conversion disorder, functional neurological disorder
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1. Introduction 
Dissociative seizures (DS) are also known as psychogenic, non-epileptic, or conversion 
seizures, and are classified as dissociative [1] and functional neurological symptom [2]  
disorders in ICD-10 and DSM-5 respectively.  The estimated prevalence of the disorder is 
approximately 2-33 per 100,000 [3].  Diagnosis is typically made in early adulthood, although 
the disorder occurs across the lifespan [4-6].  Females are known to be over-represented 
[7].  Symptoms of DS differ considerably from case to case, but the events often superficially 
resemble epileptic seizures (ES), including pronounced alterations in awareness, 
sensation/perception and volition.  DS are diagnosed on the basis of exclusion of clear 
organic causation (e.g. epilepsy, syncope, transient ischaemic attacks, hypoglycaemia), with 
the diagnostic ‘gold standard’ being a video-recorded typical seizure in the absence of 
associated epileptogenic abnormalities in EEG output (video-EEG) [8].  
 
Patients with DS generally report a lack of voluntary control over seizure occurrence, with 
many being unable to identify specific and consistent environmental or internal antecedents 
to the attacks [9,10].  Nonetheless, stress is known to be a common precipitant [11].  
Abnormal responses to emotional distress or bodily arousal have been hypothesised to 
contribute to DS occurrence, in at least a proportion of cases [12-14].  Affective 
manifestations and dissociative experiences during seizures are reported frequently [15-17], 
alongside more general elevations in psychological and somatoform dissociation [13,17-20].  
Trauma, abuse, stress and family dysfunction are common risk factors [17,21-24].   
 
Heightened scores on measures of a range of affect-related variables have been observed 
commonly in this group, including alexithymia [25-28], emotional dysregulation [17,28-33], 
anxiety [15,17,25,27,28,34,35], and depression [17,19,25,27,28,34,36].  Additionally, a limited 
number of experimental studies have indicated abnormalities in emotional processing in 
patients with DS, most commonly in responses to facial affect.  Findings include impaired 
switching from a facial emotion categorisation task [31], exaggerated interference by facial 
emotion on working memory performance [37], and reduced explicit recognition and 
attenuated autonomic responses to facial expressions relative to controls [38].  The first 
experimental study of this nature [39] reported an increased attentional bias towards angry 
faces in patients with DS (n = 19) compared to healthy controls (n = 20) (p < .05), on an 
emotional Stroop test involving preconscious processing of affectively valenced facial stimuli.  
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This attentional bias correlated positively with patients’ reports of sexual abuse (p < .05) 
and basal cortisol levels (p < .05) [39,40].  This was an important finding, as implicit 
attentional biases towards affective stimuli, particularly those of a negative or distressing 
nature, could increase overall levels of emotional arousal and distress in this patient group.  
Nevertheless, this possible implicit attentional bias requires further investigation and 
replication, before being incorporated into theoretical models and/or clinical interventions 
for DS.  
 
An issue to consider when interpreting studies of this nature in this population, is the extent 
to which the observed attentional bias is specific to this disorder, or whether it is related to 
the other comorbid psychological symptoms (e.g., anxiety and depression), commonly 
observed in this group.  There is a good evidence base to indicate, for example, that people 
with symptoms of anxiety show increased allocation of attention to threat-related stimuli 
[41,42] and individuals with depression display altered attentional allocation to negatively-
valenced stimuli [43]; thus, controlling for or exploring the influence of these symptoms 
would facilitate interpretation of findings in this area.  Furthermore, patients with DS often 
exhibit subtle neurocognitive abnormalities [27,30,44]; therefore, it is also necessary to 
account for general intellectual functioning and cognitive abilities relevant to task 
performance (e.g., facial perception).   
 
The current study aimed to replicate and extend Bakvis et al.’s findings [39] by examining 
implicit (preconscious) facial emotion processing in a larger sample of patients with DS, and 
to examine the influence of anxiety, depression and relevant cognitive abilities.  The DS 
group included in the current study had also completed a test of explicit (conscious) facial 
expression recognition, in which reduced emotion recognition and autonomic responses has 
been observed [38].  In the present experiment, behavioural performance on a pictorial 
emotional Stroop test was compared between the DS group and healthy controls.  Anxiety 
and depression were measured with a validated self-report measure, and relevant cognitive 
abilities were assessed with standardised neuropsychological tests.  It was predicted that 
patients with DS would display greater implicit attentional bias for facial emotion compared 
to the control group, and that this bias would not be explained by diminished cognitive 
performance or elevated anxiety and depression.  It was expected that the attentional bias 
would be most pronounced for angry facial expressions.  
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2. Method 
The study received ethical approval from the Joint South London and Maudsley and Institute 
of Psychiatry NHS Research Ethics Committee (reference 08/H0807/82).  Participants 
provided written informed consent prior to taking part.  The study was part of a larger 
investigation of emotional processes in patients with DS, in which patients completed 
several other tasks, self-report measures and cognitive assessments.       
 
2.1. Participants 
Patients with DS were recruited from two specialist neuropsychiatry clinics at the South 
London and Maudsley NHS Foundation Trust, UK.  Diagnosis was determined on the basis 
of video-EEG, or consensus opinion of two neurologists, or a neurologist and a 
neuropsychiatrist.  Control participants were recruited through websites and the 
distribution of fliers in the local community.  All participants were between 18 and 65 years 
old, English-speakers, and had no documented evidence of intellectual disability.     
 
Participants with documented diagnoses of current major depression, anxiety, substance 
dependence, psychosis, or major neurological disorder (including epilepsy, suspected or 
confirmed) were excluded from both groups.  The assessment of the presence of these 
diagnoses in the DS sample was based on medical records, neuropsychiatric assessment (JM 
or other consultant neuropsychiatrist), or referral documentation from other clinicians (e.g., 
epileptologists).  The presence of these diagnoses in healthy controls was based on self-
report.  Patients with DS were recruited prior to having commenced psychological 
treatment for DS.   
 
2.2. Emotional Stroop task 
The facial stimuli were pictures of models displaying angry, happy and neutral facial 
expressions from the ‘Pictures of Facial Affect’ [45].  The faces were cropped digitally, and 
coloured in a transparent shade of red, yellow or green, allowing the facial expressions and 
features to remain clearly visible.  The faces were backwardly masked by neutral patterns, 
consisting of several high-contrast concentric ovals in red, green or yellow, presented on a 
black background.  Examples of the stimuli can be found in Supplementary File 1.  There 
were 30 facial stimuli in total, comprising 10 examples each of happy, angry and neutral 
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expressions.  All 30 of the facial stimuli were presented three times within the experiment, 
each presented once in red, yellow, and green, yielding a total of 90 experimental trials.  
The 90 trials were presented in a different pseudo-randomised order for each participant, 
with no more than two stimuli of the same colour or expression presented consecutively.  
 
The task began with nine practice trials.  These consisted of a 750 millisecond (msec) 
presentation of a fixation cross, directly followed by a neutral pattern stimulus.  Participants 
were requested to say aloud the colour in which the pattern was displayed as quickly as 
possible, with response onset registered with a voice key device.  On registration of the 
verbal response, the pattern disappeared.  The inter-stimulus interval (ISI) was fixed at two 
seconds, during which the screen was blank.   
 
The experimental trials were identical to the practice trials, with the addition of individual 
facial stimuli presented for 17 msec, immediately after the fixation cross and prior to the 
masking (pattern) stimuli.  This was the quickest refresh rate of the integrated laptop 
monitor used in the experiment; therefore, this was the minimum possible presentation 
time for the facial stimuli.  Previous research has suggested that this is within the range (1-
33 msecs) that typically precludes conscious awareness of stimuli [46,47].  The face and 
masking stimuli on each trial were presented in the same colour.  Participants were required 
to name aloud the colour of the masking stimulus as quickly as possible.  The ISI varied 
between 2-4 seconds.  
 
2.3. Awareness check 
An objective awareness check was carried out after participants had completed the 
experimental task.  The task involved a forced-choice procedure of 30 trials (identical to the 
experimental trials), in which participants were explicitly required to select which facial 
expression had been shown on each trial, from three choices (happiness, anger, neutral).   
     
2.4. Cognitive measures 
The two subscale version of the Wechsler Abbreviated Scale of Intelligence (WASI) [48] 
was used to assess general intellectual functioning.  A standard version of the Stroop test 
[49] was administered to assess basic executive functioning (response 
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inhibition/attention/processing speed).  Furthermore, the Benton Facial Recognition Test 
[50] measured basic perceptual processing of facial stimuli. 
 
 
 
2.5. Self-reported psychological symptoms 
The Hospital Anxiety and Depression Scale (HADS) [51] measured self-reported current 
(non-somatic) symptoms of anxiety and depression.  Scores range from 0-21, with values of 
8-10 representing borderline depression and anxiety, and scores of 11 or over being 
indicative of clinical levels of depression or anxiety on the respective subscales. 
 
2.6. Data analysis 
Data analysis was carried out in SPSS (v22).  Between group comparisons of participant 
characteristics and performance on the cognitive tests were assessed with t-tests, Mann-
Whitney or chi-squared tests.   
 
For the awareness check, a mixed factorial Analysis of Covariance (ANCOVA) was used to 
examine the effect of group (between-subjects; DS, control) and facial expression (within-
subjects; happiness, anger, neutral) on percentage correct scores.  Binomial tests were used 
to determine whether the percentage correct scores were significantly different from 
chance performance.  
 
Colour-naming errors, absolute reaction times (RTs) and attentional bias (AB) scores on the 
emotional Stroop test were analysed with mixed factorial ANCOVAs, with years of 
education (YoE) and HADS Depression and Anxiety scores included as covariates. Cognitive 
test scores were not included as covariates due to no group differences being observed on 
these measures. 
 
Reaction time data cleaning followed the procedures described by Bakvis et al. [39], for 
consistency.  AB scores were calculated by subtracting the mean RT for the neutral 
condition from the mean RT for each expression (happy or angry).  For AB scores, the 
within-subjects factor had just two levels (expression: anger, happiness).  Post-hoc tests 
8 
 
were conducted when appropriate, with an alpha level of p < .01 applied to test for 
significance. 
 
Possible relationships between experimental dependent variables and patient characteristics 
were also examined in the DS group, including seizure frequency and duration of DS 
disorder.  These were investigated using two-tailed Pearson’s or Spearman’s correlations 
and a stringent alpha level of p < .01 was adopted for significance testing, due to multiple 
testing.    
 
3. Results  
3.1. Participant characteristics 
Table 1 provides details of participants’ characteristics.  There were no between-group 
differences in age, gender, or handedness.  There was an almost significant between-groups 
difference in YoE.  The clinical group demonstrated significantly higher Anxiety and 
Depression scores than controls and were more likely to be taking prescribed medications.  
Thirteen patients with DS (34%) were taking antiepileptic drugs (AEDs), and 16 patients 
(42%) reported taking antidepressant medications.  For the DS group, the median current 
monthly seizure frequency was 4.33 (interquartile range = 14.6).  The median length of time 
since seizure onset was 54 months (interquartile range = 96.8 months). 
 
3.2. Cognitive tests 
A summary of scores on the cognitive tests can be found in Table 2.  There were no 
significant group differences on any of the cognitive tests administered.  The groups were, 
therefore, well matched for cognitive performance and so these scores were not added to 
the analysis of emotional Stroop performance as covariates. 
 
3.3. Awareness check 
Table 3 displays descriptive statistics for the awareness test.  Accuracy scores were lower 
in the DS group for all three conditions; however, after covarying for YoE (which was also 
lower in the DS group, see above), there was no overall significant effect of group on the 
percentage of correct responses (F (1, 78) = 3.28, p = .074, η2p  = .04).  There was also no 
overall effect of expression (F (2, 156) = 1.34, p = .27, η2p  = .017), and no interaction of 
expression x group (F (2, 156) = .402, p = .669, η2p = .005).  YoE was not a significant 
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covariate (F (1, 78) = .012, p = .92, η2p = .000).  The same pattern was observed when 
HADS Anxiety and Depression scores were added as covariates, although anxiety did 
covary significantly with percentage correct scores (F (1, 76) = 4.27, p = .042, η2p = .053); 
higher anxiety scores were associated with better awareness in all three conditions.   
 
Binomial tests indicated that the mean percentage correct scores for some expressions 
were above chance in one or both groups (see asterisked values in Table 3).  In the DS 
group, performance was above chance for happy faces, whereas performance was better 
than chance for angry and happy faces in the control group.  Nevertheless, 79% of the DS 
group and 72% of controls reported no awareness of having seen any facial stimuli during 
the test at all.  Those participants reporting awareness of having seen the stimuli often 
were not able to report exactly what they had seen (e.g. specific facial expressions).   
 
3.4. Emotional Stroop test 
Table 4 displays the descriptive statistics for the emotional Stroop task. 
 
Colour-naming errors 
The ANCOVA revealed no significant effect of group on colour-naming errors (F (1, 76) = 
1.81, p = .183, η2p = .023); however, a significant effect of expression was evident (F (1.73, 
131.2) = 8.10, p = .001, η2p = .096) with neutral expressions associated with most erroneous 
responses (marginal mean = .21, SE = .091), and happy faces the fewest (marginal mean = 
.71, SE = .21).   
 
There was no significant group x expression interaction (F (1.73, 131.2) = 1.11, p = .33, η2p = 
.014).  YoE (F (1, 76) = 6.46, p = .013, η2p = .078) and HADS Anxiety (F (1, 76) = 5.78, p = 
.019, η2p = .071) were significant covariates, but HADS Depression was not (F (1, 76) = .75, 
p = .39, η2p = .010).  Higher Anxiety scores were associated with fewer colour-naming 
errors in all conditions.   
    
Absolute RTs 
No significant main effect of expression (F (2, 152) = .39, p = .68, η2p = .005), group (F (1, 
76) = .21, p = .65, η2p = .003), or group x expression interaction (F (2, 152) = 2.61, p = .077, 
η2p = .033) was observed for absolute RTs.  None of the covariates were significant.   
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Attentional bias scores 
The ANCOVA demonstrated a significant group effect for attentional bias (AB) scores (F (1, 
76) = 4.36, p = .04, η2p = .054), with the DS group exhibiting significantly greater AB scores 
(marginal mean = 10.07, SE = 3.98) compared to control participants (marginal mean = -
2.57, SE = 3.68).  There was no overall effect of expression (F (1, 76) = .83, p = .37, η2p = 
.011), and no expression x group interaction (F (1, 76) = .56, p = .46, η2p = .007).  The only 
significant covariate was HADS Depression scores (F (1, 76) = 4.13, p = .046, η2p = .052), 
with higher depression scores associated with reduced AB scores for both happy and angry 
faces.   
 
Exploratory analyses 
There was a highly significant positive relationship between seizure frequency and AB scores 
for happy faces (r = .469, p = .003), which remained significant after controlling for YoE and 
HADS scores in a partial correlation (r = .662, p = .001).  None of the other correlations 
between participant characteristics and AB scores were significant at an alpha level of p < 
.01.   
 
 
4. Discussion 
This study tested the hypothesis that implicitly processed facial affect would interfere 
disproportionately with performance on an emotional Stroop test, and that this group effect 
would not be explained by the presence of anxiety, depression, or differences in relevant 
cognitive abilities.  As predicted, patients with DS showed greater AB scores for facial 
emotion, relative to the control group, whilst controlling for psychological symptoms (i.e. 
anxiety, depression).  Furthermore, the groups were well matched for performance on 
relevant cognitive tests, and the awareness check data indicated that there were no 
between-group differences in awareness of the masked facial stimuli, so it is unlikely that 
either of these factors explain the findings.   
 
Together with Bakvis et al.’s study [39], these results provide strong evidence for an 
exaggerated attentional bias for facial emotion in this group; this attentional bias does not 
appear to be attributable to possible confounding variables.  At this stage, it is only possible 
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to hypothesise about the causation of such a bias.  One possible explanation is that 
individuals with DS are more likely to have experienced childhood family contexts in which 
emotional expression and experience is inhibited [9,21], and therefore, the ‘norm’ could be 
affectively neutral or less intense facial expressions.  In this case, outward signals of emotion 
in others could potentially be particularly salient stimuli for some people with DS, especially 
the relatively intense expressions such as happiness and anger, used in this study.   
  
An alternative possibility is that the presence of conflict, abuse, and neglect in the histories 
of some patients with the diagnosis [17,22,52,53] may have contributed to more frequent 
than average exposure to negative facial expressions, potentially sensitising them to signs of 
anger/hostility and/or signs of social acceptance or approval. Of relevance to this 
interpretation are our findings reported elsewhere [17,38] in this same sample, of higher 
rates of self-reported trauma (including total lifetime traumas, sexual and physical abuse), 
greater impact of traumas, and more current interpersonal conflict and abandonment 
concerns, relative to controls.  It should be noted; however, that in preliminary 
correlational analyses, there were no significant relationships between these factors and the 
AB observed in this experiment.  
 
A final possible explanation for the AB observed here is that it could be secondary to the 
disorder itself.  The presence of this chronic, distressing and debilitating disorder could be 
sufficient to make patients more socially anxious, and thus excessively alert to signals of 
threat or acceptance in others.  One means of examining the latter possibility is to assess 
whether the attentional bias ameliorates with resolution of DS symptoms following 
treatment.   
 
In the present study, the lack of interaction between expression and group in the analysis of 
AB scores suggested that the attentional bias reflected a tendency towards hypervigilance 
for both positive and negative facial expressions, in contrast to the specificity of the effect to 
anger in Bakvis et al.’s study [39].  Other studies have also found differences in responses to 
positive affective stimuli in this group [54] and effects spanning both positive and negative 
facial expressions in different paradigms [31].   Additional studies exploring differential 
responding to positive and negative stimulus categories would be informative in this group.  
Furthermore, studies aiming to examine attentional biases to other, possibly relevant stimuli 
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might also be of value, such as those relating to somatic experiences and awareness, illness, 
or trauma. 
 
An important finding in the current study was that depression scores were found to be a 
significant covariate throughout the analyses of AB scores.  This finding highlights the 
necessity of controlling for this possible confound in studies of affective processes in this 
patient group.  The finding that elevated symptoms of depression were associated with 
reduced attentional bias for facial emotion in this sample contrasts with the pattern 
observed in individuals with depression more generally, in which attentional biases (i.e. 
greater interference) towards negative (sad) facial expressions have been reported [43,55].  
Symptoms of depression in patients with DS might influence affective processing in a 
different way to individuals with clinical depression without DS, perhaps causing automatic 
avoidance of affective stimuli as would be suggested by the association with reduced AB 
scores observed here.  Therefore, it would be beneficial to further examine the ways in 
which symptoms of anxiety and/or depression influence affective processing in patients with 
DS, compared to individuals with depression/anxiety alone.   
           
The significant relationship between seizure frequency and AB scores for happy expressions 
suggests that those patients having the most seizures (i.e. greater disorder severity) 
automatically allocated more attention to positive facial expressions than those with less 
frequent seizures.  This tendency to automatically seek out positive experiences and 
interpersonal interactions in the environment could represent an aspect of resilience for 
these individuals.  On the other hand, a tendency to attend automatically to positive social 
cues (or positive stimuli more generally) might serve as a means of reducing or avoiding 
subjective emotional distress, and this could be a predispositional style of responding that 
could act as a risk factor for developing the disorder.  Further studies might valuably seek to 
explore these findings further by examining responsivity to both negative/threatening and 
positive/appetitive stimuli in those with recent onset DS, compared to those with chronic 
symptoms, and in those whose seizures have remitted. 
  
4.1. Limitations 
With regards to the experimental task, there are a few limitations to note.  We only 
included one exemplar of positive and one of negative facial expressions; therefore, we have 
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not provided information on attentional processing of other possibly relevant expressions 
such as fear, disgust, or empathy, for example.  In addition, the use of a neutral face as a 
control condition is questionable, because neutral faces could carry emotional significance 
for people with DS (and other psychological disorders with similar risk factors).   
 
Furthermore, whilst the traditional interpretation of the emotional Stroop task is that it 
measures attentional bias (facilitated attention) towards specific stimulus categories [56], 
others have suggested that it might predominantly measure cognitive avoidance or 
disengagement [57,58].  We would argue that the cognitive avoidance explanation is less 
plausible for the task used here, because of the short duration of stimulus presentation (17 
msecs) and associated impaired subjective awareness of the stimuli; cognitive/attentional 
avoidance is thought to occur at a later stage of processing than the initial precognitive 
evaluation of stimuli that would operate during the subliminal presentations used here.    
Future studies might seek to explore further our findings with other attentional processing 
tasks, such as variations of the visual probe, visual search, or spatial cueing tasks, for 
example. Tasks that vary stimulus duration, particularly comparing supraliminal and 
subliminal presentations of stimuli, may also provide insights into the automaticity and/or 
nature of these cognitive processing differences.    
 
A related point is that the AB findings reported here and by Bakvis et al. [39] were in the 
order of milliseconds, and so it is questionable whether these group differences are clinically 
significant.  The effect sizes presented here suggest that this may be the case, in addition to 
the finding that the AB for happy faces was associated with greater seizure frequency.  
Nevertheless, it would be interesting to examine whether the AB is responsive to 
psychological treatments, perhaps using prospective before/after treatment designs, and/or 
to examine whether post-treatment changes in AB for facial affect correlate with other 
important outcomes, such as self-reported psychosocial functioning, (social) anxiety, mood 
symptoms, or avoidance behaviours.   
 
In terms of patient recruitment, the present inclusion of patients diagnosed on clinical 
grounds rather than video-EEG only could leave open the possibility of misdiagnosis; 
however, we included these individuals to increase statistical power and ensure 
representativeness of this population, because whilst video-EEG is the current ‘gold 
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standard’ in diagnosing DS, it is not currently available universally, and does not definitively 
exclude the possibility of comorbid epilepsy.  Another potential sampling limitation was the 
lack of a clinical comparison group.  Whilst control groups of patients with epilepsy are not 
appropriate for studies of this nature due to possible differences in facial expression 
processing in people with that condition [59,60], other suitable comparison groups could be 
individuals with depression or anxiety without additional medically unexplained symptoms, 
samples with other functional neurological symptoms (e.g. functional motor or sensory 
symptoms), or other somatoform disorders.   
 
An additional limitation relating to the clinical sample was the use of AEDs and 
antidepressants in a proportion of patients, despite the exclusion of comorbid epilepsy 
(suspected or confirmed) or current affective disorder.  Ongoing AED use in this sample 
might reflect a range of factors, including patients’ reluctance to stop taking AEDs due to 
resistance to a psychological explanation for the disorder, or only gradual withdrawal of 
AEDs by clinicians to avoid a potential nocebo effect.  Antidepressant medications were 
prescribed for patients in this sample for a range of reasons, including previous affective 
disorder, anxiety disorders, or other functional neurological symptoms (e.g., fatigue, pain).  
Given the similar results observed in an unmedicated sample by Bakvis et al., it is unlikely 
that medication use fully accounts for the findings reported here; however, it remains a 
possibility that it may have had some influence.   
 
Finally, the inclusion of anxiety and depression as covariates in the ANCOVAs could be 
queried because these symptoms could be viewed as a part of the disorder itself, in line with 
arguments presented by Miller and Chapman [61], for example.  However, we argue that 
this suggestion is not applicable here, for several reasons.  Anxiety and depression are not a 
formal part of the diagnosis of DS, and whilst these symptoms are often elevated in this 
group relative to non-clinical controls, this is not always the case, with many patients 
reporting no subjective psychological symptoms and a large proportion of DS patients who 
do not have a comorbid psychiatric diagnosis.  Furthermore, many patients with DS 
experience symptoms of anxiety and depression secondarily to the distressing and disabling 
disorder itself.  As such, whilst anxiety and depression are common comorbidities of DS, 
they are not inherently part of the disorder, and as such we feel that our approach is valid 
and preferable to having not measured nor accounted for the presence of these symptoms.  
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As suggested above, future studies might seek to include clinical control groups with 
comparable anxiety/depression symptoms, as an alternative approach to exploring this issue. 
 
4.2. Clinical implications  
The findings presented here have several potential clinical implications, particularly in the 
context of the broader findings on emotional processing in this and related populations, 
such as other functional neurological or dissociative disorder subgroups.  A pattern of 
preconscious hypervigilance to facial emotion (i.e., scanning the environment for social 
emotional cues), combined with conscious misinterpretation of facial expressions as 
demonstrated in this same sample [38] or deficits in ‘theory of mind’ reported by others 
[62], could be associated with substantial difficulties in social interactions in daily life and 
possibly within psychological interventions for the disorder.  These biases, therefore, may 
play an important role in maintaining the disorder, and possibly precipitating individual 
seizures.  Psychological interventions aimed at reducing preconscious attentional allocation 
to facial emotion (i.e., attentional bias modification), and improving explicit facial expression 
recognition and mentalising (e.g., within CBT protocols), might well yield significant benefits 
for some patients with this disorder.   
 
 
5. Conclusions 
The results of the study provide additional support for the proposal of an exaggerated 
attentional bias towards implicitly processed emotional facial expressions in patients with 
DS.  Such an attentional bias might contribute to an acute increase in affective arousal when 
signs of emotion are detected, and thus could directly contribute to the triggering of 
individual seizures.  Moreover, the hypervigilance to subtle signs of affect in others might 
also contribute to generally elevated arousal on an ongoing basis.  Further research is 
needed to explore attentional biases in this group, using a wider range of experimental 
paradigms, and in relation to other relevant stimuli.  Additionally, future studies in this area 
might attempt to better ascertain the clinical significance of the findings reported here, 
particularly in patients at different stages in the disorder (i.e., recent onset, chronic 
symptoms, in remission) and/or at different points in treatment (i.e., before/after).   
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Table 1. Participant characteristics 
 DS 
(n = 38) 
Controls  
(n = 43) 
Test statistics 
 
Age (years) 
  Median (IQR) 
 
41.5 (22.5) 
 
36 (20) 
U (81) = 720,  
p = .358 
Gender  Male = 8 (21%) 
Female = 30 (79%) 
Male = 8 (19%) 
Female = 35 (81%) 
X2 (1, n = 81) = 
.076,  p = .782 
Handedness Right = 29 (76%) 
 
Right = 38 (88%) X2 (1, n = 81) = 
2.05,  p = .152 
Ethnicity White = 30 (79%) 
Non-white = 8 (21%) 
White = 28 (65%) 
Non-white = 15 (35%) 
X2 (1, n = 81) = 
1.9, p = .168 
YoE 
  Median (IQR) 
 
13 (3.25) 
 
14 (5) 
U (81) = 616,  
p = .054 
Qualifications GCSEs / none = 14 
(37%) 
Further / higher  
= 24 (63%) 
GCSEs / none = 9 
(21%) 
Further / higher = 34 
(79%) 
X2 (1, n = 81) = 
.251, p = .113 
Medication use Yes = 27 (71%) 
No = 11 (29%) 
Yes = 10 (23%)  
No = 33 (78%) 
X2 (1, n = 81) = 
18.6, p < .001 
Medical 
diagnosis  
Yes = 23 (61%) 
No = 15 (39%) 
Yes = 6 (14%) 
No = 37 (86%) 
X2 (1, n = 81) = 
19.04, p < .001 
HADS (Mean, 
SD) 
    Anxiety 
    
    Depression 
 
 
9.68 (4.07) 
 
7.21 (4.23) 
 
 
5.28 (3.20) 
 
2.26 (2.43) 
 
 
t (79) = -5.44, p 
< .001 
t (57.4) = -6.35, 
p < .001 
SD = standard deviation    IQR = interquartile range   
YoE: years of full-time education (or equivalent) HADS = Hospital Anxiety & Depression Scale  
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Table 2. Cognitive measures 
 DS Controls Test 
statistics 
WASI 
FSIQ (Mean, SD) 
 
104.1 (14.7) 
 
108.1 (13.1) 
t (79) = 1.29,  
p = .198 
Vocabulary T scores 
(Mean, SD) 
 
51.8 (11.3) 
 
55.2 (9.8) 
t (79) = 1.46,  
p = .148 
Matrix Reasoning T scores  
(Median (IQR) 
 
54.5 (10) 
 
56 (15) 
U (81) = 730,  
p = .410 
BFRT  
Median (IQR) 
 
49 (7) 
 
49 (5) 
U (80) = 631,  
p = .109 
 Stroop test         
 Mean (SD) 
52.8 (8.3) 51.5 (9.01) t (78) = -.656, 
p = .514 
SD = standard deviation; WASI = Wechsler Abbreviated Scale of Intelligence; FSIQ = Full-Scale IQ;  
DS = dissociative seizures; IQR = interquartile range; BFRT = Benton Facial Recognition Test 
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Table 3. Awareness check for subliminally presented stimuli 
 DS  
(n = 38) 
Controls  
(n = 43) 
Angry faces (% correct)   
          Mean (SD)  42.1 (24.2) 53.3 (24.7)* 
Neutral faces (% correct)   
          Mean (SD) 46.1 (23.3) 50.2 (25.9) 
Happy faces (% correct)   
          Mean (SD) 52.9 (22.9)* 60 (29.2)* 
DS = dissociative seizures; SD = standard deviation; IQR = interquartile range 
* denotes variables significantly differing from chance performance (p < .01) 
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Table 4. Emotional Stroop test – descriptive statistics (uncorrected values) 
 DS  
(n = 38) 
Controls  
(n = 43) 
Colour-naming errors  
(%; mean, SD) 
     Happy          
     Angry 
     Neutral 
 
 
.18 (.75) 
.53 (1.82) 
.61 (1.31) 
 
 
.23 (.86) 
.23 (1.13) 
.78 (2.28) 
Absolute RTs (msecs; mean, SD) 
     Happy 
     Angry 
     Neutral 
 
622.9 (94.9) 
622.4 (93.4) 
617.1 (97.7) 
 
603.1 (79.8) 
605.5 (80.6) 
602.9 (83.9) 
AB scores (msecs; mean, SD) 
     Happy  
     Angry 
 
5.79 (27.6) 
5.31 (27.1) 
 
.207 (20.6) 
2.65 (21.6) 
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Supplementary Material 
Supplementary file 1 – Experimental stimuli 
 
Example facial stimuli 
 
Happiness Anger Neutral 
 
   
 
Full list of facial stimuli (from Ekman & Friesen, 1976) 
Experimental stimuli: 001, 003, 006, 014, 018, 021, 029, 030, 033, 034, 038, 041, 042, 
044, 047, 048, 053, 056, 057, 061, 065, 074, 080, 083, 093, 096, 099, 101,105, 110 
 
 
Masking stimuli 
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